TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ACRS

Aclaris Therapeutics Inc

Healthcare · Biotechnology

5.30$ -2.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Aclaris Therapeutics Inc (ACRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 180 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACRS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
218 197 174 161 182 220 198 189 176 160 199 180
123 129 135 118 132 126 109 104 101 151 110 98
39 40 36 23 48 25 30 25 25 20 29 19
103 119 128 111 128 114 105 100 96 91 105 92
0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.2 4.7 5.6 4.8 6.2
-84 – 0.0 – – – – – – – – –
4.3 – – – – – – – – – – –
6.9 0.3 – – – – – – – – – –
62 40 32 27 52 65 54 57 55 57 55 55
27 31 20 16 19 32 22 27 26 29 27 28
0.3 0.4 0.5 0.4 0.5 0.5 0.5 0.5 0.5 0.6 0.6 –
9.6 8.9 11 7.3 7.7 4.7 6.4 8.8 9.2 13 15 16
156 157 142 134 130 156 144 132 120 103 144 125
-769 -771 -788 -799 -806 -903 -918 -933 -948 -968 -988 -1,009
71 71 71 71 71 95 122 123 123 123 129 143

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?